EVO News
Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals
Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 GoalsPR NewswireHAMBURG, Germany, Nov. 5, 2026 Financial performance: Q3 and nine-month Group revenue...
PR Newswire
Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals
Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 Goals Evotec Reports Third Quarter and Nine-Month 2026 Results: Building Growth Momentum Toward 2030 GoalsPR NewswireHAMBURG, Germany, Nov. 5, 2026 Financial performance: Q3 and nine-month Group revenue...
PR Newswire
Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026 Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026PR NewswireHAMBURG, Germany, Oct. 29, 2026 HAMBURG, Germany, Oct. 29, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime...
PR Newswire
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management BoardPR NewswireHAMBURG, Germany, Oct. 15, 2026Will lead Evotec's global scientific strategy and drive...
PR Newswire
(RTTNews) - Evotec SE (EVTG.DE, EVTCY.PK, EVO), a German healthcare company, announced preliminary results for the first nine months of 2026 that came in above market expectations, while reaffirming its fiscal 2026 guidance...
Nasdaq News: Markets
Evotec Announces Chief Scientific Officer Transition Evotec Announces Chief Scientific Officer TransitionPR NewswireHAMBURG, Germany, Sept. 29, 2026 Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE...
PR Newswire
Gainers
Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's after-market session. The company's market cap stands at $36.9 million.
Evotec (NASDAQ:EVO) stock rose 8.44% toread more...
Benzinga
Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies Just - Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies PR Newswire SEATTLE and HAMBURG, Germany, Sept. 9, 2026...
PR Newswire
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors PR Newswire HAMBURG, Germany and HALLBERGMOOS...
PR Newswire
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases PR Newswire HAMBURG, Germany, Aug. 6, 2026 Collaboration combines Odyssey's disease...
PR Newswire
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has selected Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), a global life science company specializing in drug...
Business Wire